Topics

1. Artera AI versus genomic testing (ie Decipher, Oncotype DX, and Prolaris) for predicting prostate cancer outcomes

2. Radiation therapy versus focal ablative therapies for managing biochemical recurrence of prostate cancer

3. PCNL versus Calyxo CVAC system for treating a 2 cm lower pole stone

4. Uretero-ureterostomy versus upper pole heminephrectomy for treatment of poorly functioning (10-15%) upper pole moiety in duplex kidney

6:00pm Cocktail Hour

7:00pm Program

Children’s Hospital of Philadelphia The Hub for Clinical Collaboration 3500 Civic Center Boulevard 1st Floor, Lecture Hall Philadelphia, PA 19104